These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2737100)

  • 21. A study of olfactory testing in patients with rhinological pathology in the ENT clinic.
    Philpott CM; Rimal D; Tassone P; Prinsley PR; Premachandra DJ
    Rhinology; 2008 Mar; 46(1):34-9. PubMed ID: 18444490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of olfaction in patients with pemphigus vulgaris.
    Meric A; Dogan R; Veyseller B; Su O; Ozucer B; Tugrul S; Ozturan O
    Am J Rhinol Allergy; 2014; 28(2):e90-4. PubMed ID: 24717939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olfactory clearance: what time is needed in clinical practice?
    Philpott CM; Wolstenholme CR; Goodenough PC; Clark A; Murty GE
    J Laryngol Otol; 2008 Sep; 122(9):912-7. PubMed ID: 18036276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Screening of olfaction with smell diskettes].
    Simmen D; Briner HR; Hess K
    Laryngorhinootologie; 1999 Mar; 78(3):125-30. PubMed ID: 10226979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of diagnostic findings using different olfactory test methods.
    Tsukatani T; Reiter ER; Miwa T; Costanzo RM
    Laryngoscope; 2005 Jun; 115(6):1114-7. PubMed ID: 15933533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Connecticut olfactory test (CCCRC) adapted to Brazil.
    Fenólio GHM; Anselmo-Lima WT; Tomazini GC; Compagnoni IM; Amaral MSAD; Fantucci MZ; Peixoto PPL; Guimarães AF; Guimarães RES; Sakano E; Valera FCP; Tamashiro E
    Braz J Otorhinolaryngol; 2022; 88(5):725-732. PubMed ID: 33272838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of unilateral examination in olfactometry.
    Furukawa M; Kamide M; Miwa T; Umeda R
    Auris Nasus Larynx; 1988; 15(2):113-6. PubMed ID: 3207411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lyon clinical olfactory test: validation and measurement of hyposmia and anosmia in healthy and diseased populations.
    Rouby C; Thomas-Danguin T; Vigouroux M; Ciuperca G; Jiang T; Alexanian J; Barges M; Gallice I; Degraix JL; Sicard G
    Int J Otolaryngol; 2011; 2011():203805. PubMed ID: 22046188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connecticut (CCCRC) Olfactory Test: Normative Values in 426 Healthy Volunteers.
    Veyseller B; Ozucer B; Karaaltin AB; Yildirim Y; Degirmenci N; Aksoy F; Ozturan O
    Indian J Otolaryngol Head Neck Surg; 2014 Jan; 66(1):31-4. PubMed ID: 24605298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Olfactory dysfunction in patients with chronic rhinosinusitis.
    Sánchez-Vallecillo MV; Fraire ME; Baena-Cagnani C; Zernotti ME
    Int J Otolaryngol; 2012; 2012():327206. PubMed ID: 22685462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. African Gene Flow Reduces Beta-Ionone Anosmia/Hyposmia Prevalence in Admixed Malagasy Populations.
    Razafindrazaka H; Pereda-Loth V; Ferdenzi C; Heiske M; Alva O; Randriamialisoa M; Costedoat C; Signoli M; Talou T; Courtade-Saidi M; Boland A; Deleuze JF; Rouby C; Radimilahy C; Letellier T; Bensafi M; Pierron D
    Brain Sci; 2021 Oct; 11(11):. PubMed ID: 34827404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Unifying Data-Driven Model of Human Olfactory Pathology Representing Known Etiologies of Dysfunction.
    Lötsch J; Ultsch A; Hummel T
    Chem Senses; 2016 Nov; 41(9):763-770. PubMed ID: 27566724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of various forms of olfactory disorders].
    Rous J
    Cesk Otolaryngol; 1977 Aug; 26(4):209-15. PubMed ID: 922918
    [No Abstract]   [Full Text] [Related]  

  • 34. [Objective determinations of anosmia].
    DE KLEYN A
    Ned Tijdschr Geneeskd; 1948 Oct; 92(44):3591. PubMed ID: 18099303
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparable responses to a wide range of olfactory stimulation in women and men.
    Lillqvist M; Claeson AS; Zakrzewska M; Andersson L
    Sci Rep; 2023 Jun; 13(1):9059. PubMed ID: 37270617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Odor perception and symptoms during acrolein exposure in individuals with and without building-related symptoms.
    Palmquist E; Claeson AS
    Sci Rep; 2022 May; 12(1):8171. PubMed ID: 35581334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical Intolerance Is Associated With Altered Response Bias, not Greater Sensory Sensitivity.
    Andersson L; Sandberg P; Åström E; Lillqvist M; Claeson AS
    Iperception; 2020; 11(6):2041669520978424. PubMed ID: 33425314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered Olfactory Function in Patients with Systemic Lupus Erythematosus.
    Chen Q; Qiu F; Liu H; Li X; Li J
    Med Sci Monit; 2019 Aug; 25():5929-5933. PubMed ID: 31395849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of chemosensory function.
    Doty RL
    World J Otorhinolaryngol Head Neck Surg; 2018 Mar; 4(1):11-28. PubMed ID: 30035257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling in persons with multiple chemical sensitivity before and after a controlled n-butanol exposure session.
    Dantoft TM; Skovbjerg S; Andersson L; Claeson AS; Engkilde K; Lind N; Nordin S; Hellgren LI
    BMJ Open; 2017 Feb; 7(2):e013879. PubMed ID: 28232466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.